Dose escalation study of desmoteplase in acute ischemic stroke "DEDAS"

Completed

Phase N/A Results

Summary of Purpose

To assess the safety and thrombolytic efficacy of intravenous desmoteplase (vampire bat plasminogen activator) in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Paion GmbH

Trial Design

Multicenter, multinational, double-blind, placebo-controlled, randomized Phase II trial.

Contacts

  • Dr. Dirk Eyding or Dr. Angelo Stergiou PAION GmbH Martinstr. 10-12 Aachen, Germany 52062

    d.eyding@paion.de